(Q94608381)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18039452%20AND%20SRC:MED&resulttype=core&format=json

17 May 2020

title

[Early interruption of clinical trials: too good to be true?] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18039452%20AND%20SRC:MED&resulttype=core&format=json

17 May 2020

author name string

J Latour-Pérez

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18039452%20AND%20SRC:MED&resulttype=core&format=json

17 May 2020

J B Cabello-López

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18039452%20AND%20SRC:MED&resulttype=core&format=json

17 May 2020

publication date

1 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18039452%20AND%20SRC:MED&resulttype=core&format=json

Medicina intensiva / Sociedad Española de Medicina Intensiva y Unidades Coronarias

17 May 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18039452%20AND%20SRC:MED&resulttype=core&format=json

17 May 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18039452%20AND%20SRC:MED&resulttype=core&format=json

17 May 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18039452%20AND%20SRC:MED&resulttype=core&format=json

17 May 2020

page(s)

518-520

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18039452%20AND%20SRC:MED&resulttype=core&format=json

Multiplicity in randomised trials II: subgroup and interim analyses

17 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2807%2974859-3

7 January 2021

Practical problems in interim analyses, with particular regard to estimation

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2807%2974859-3

7 January 2021

Randomized trials stopped early for benefit: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2807%2974859-3

7 January 2021

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2807%2974859-3

7 January 2021

A proposed charter for clinical trial data monitoring committees: helping them to do their job well

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2807%2974859-3

7 January 2021

Commercial influence and the content of medical journals

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2807%2974859-3

7 January 2021

When (not) to stop a clinical trial for benefit.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2807%2974859-3

7 January 2021

Interim analysis: the alpha spending function approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2807%2974859-3

7 January 2021

Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2807%2974859-3

7 January 2021

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2807%2974859-3

7 January 2021

A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2807%2974859-3

7 January 2021

Intensive insulin therapy in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2807%2974859-3

7 January 2021

Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2807%2974859-3

7 January 2021

10.1016/S0210-5691(07)74859-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18039452%20AND%20SRC:MED&resulttype=core&format=json

17 May 2020

1 reference